Abstract:BackgroundOrthopaedic biomaterials are susceptible to biofilm formation. A novel lipid-based material has been developed that may be loaded with antibiotics and applied as an implant coating at point of care. However, this material has not been evaluated for antibiotic elution, biofilm inhibition, or in vivo efficacy.Questions/purposes(1) Do antibiotic-loaded coatings inhibit biofilm formation? (2) Is the coating effective in preventing biofilm in vivo?MethodsPurified phosphatidylcholine was mixed with 25% amikacin or vancomycin or a combination of 12.5% of both. A 7-day elution study for coated titanium and stainless steel coupons was followed by turbidity and zone of inhibition assays against Staphylococcus aureus and Pseudomonas aeruginosa. Coupons were inoculated with bacteria and incubated 24 hours (N = 4 for each test group). Microscopic images of biofilm were obtained. After washing and vortexing, attached bacteria were counted. A mouse biofilm model was modified to include coated and uncoated stainless steel wires inserted into the lumens of catheters inoculated with a mixture of S aureus or P aeruginosa. Colony-forming unit counts (N = 10) and scanning electron microscopy imaging of implants were used to determine antimicrobial activity.ResultsActive antibiotics with colony inhibition effects were eluted for up to 6 days. Antibiotic-loaded coatings inhibited biofilm formation on in vitro coupons (log-fold reductions of 4.3 ± 0.4 in S aureus and 3.1 ± 0 for P aeruginosa in phosphatidylcholine-only coatings, 5.6 ± 0 for S aureus and 3.1 ± 0 for P aeruginosa for combination-loaded coatings, 5.5 ± 0.3 for S aureus in vancomycin-loaded coatings, and 3.1 ± 0 for P aeruginosa for amikacin-loaded coatings (p < 0.001 for all comparisons of antibiotic-loaded coatings against uncoated controls for both bacterial strains, p < 0.001 for comparison of antibiotic-loaded coatings against phosphatidylcholine only for S aureus, p = 0.54 for comparison of vancomycin versus combination coating in S aureus, P = 0.99 for comparison of antibiotic- and unloaded phosphatidylcholine coatings in P aeruginosa). Similarly, antibiotic-loaded coatings reduced attachment of bacteria to wires in vivo (log-fold reduction of 2.54 ± 0; p < 0.001 for S aureus and 0.83 ± 0.3; p = 0.112 for P aeruginosa).ConclusionsCoatings deliver active antibiotics locally to inhibit biofilm formation and bacterial growth in vivo. Future evaluations will include orthopaedic preclinical models to confirm therapeutic efficacy.Clinical RelevanceClinical applications of local drug delivery coating could reduce the rate of implant-associated infections.

Releasing Profile of Antibiotics from a Novel Mineralized Collagen Putty with Quantifiable Drug Loading

Antibiotic release from an experimental biodegradable bone cement

In Vitro and in Vivo Evaluation of Vancomycin-Loaded PMMA Cement in Combination with Ultrasound and Microbubbles-Mediated Ultrasound

The study of mechanical and drug release properties of the mineralized collagen/polylactic acid scaffold by tuning the crystalline structure of polylactic acid

Assessing the Character of the Rhbmp-2- and Vancomycin-Loaded Calcium Sulphate Composites in Vitro and in Vivo.

Remote Eradication of Bacteria on Orthopedic Implants Via Delayed Delivery of Polycaprolactone Stabilized Polyvinylpyrrolidone Iodine

Biodegradable composites with antibiotics and growth factors for dual release kinetics

Novel microcomposite implant for the controlled delivery of antibiotics in the treatment of osteomyelitis following total joint replacement

In vitro and in vivo drug release and antibacterial properties of the novel vancomycin-loaded bone-like hydroxyapatite/poly amino acid scaffold

Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm

Sequential Release of Double Drug (graded Distribution) Loaded Gelatin Microspheres/pmma Bone Cement

Improvement of Drug Elution in Thin Mineralized Collagen Coatings with Plga-Peg-Plga Micelles

Influence of Antibiotic-Loaded Acrylic Bone Cement Composition on Drug Release Behavior and Mechanism

Mechanical properties and antibiotic release characteristics of poly(methyl methacrylate)-based bone cement formulated with mesoporous silica nanoparticles

In Vivo Effect of Quaternized Chitosan-Loaded Polymethylmethacrylate Bone Cement on Methicillin-Resistant Staphylococcus Epidermidis Infection of the Tibial Metaphysis in a Rabbit Model.

Fabrication of the Antibiotic-Releasing Gelatin/pmma Bone Cement

Hierarchical antibiotic delivery system based on calcium phosphate cement/montmorillonite-gentamicin sulfate with drug release pathways

Self-expanding PMMA composite bone cement with sustained release of gentamicin sulfate and alendronate using water absorption pathways

The Use of Quaternised Chitosan-Loaded PMMA to Inhibit Biofilm Formation and Downregulate the Virulence-Associated Gene Expression of Antibiotic-Resistant Staphylococcus

Impact of Manual Addition of Vancomycin to Polymethylmethacrylate (PMMA) Cements

Nanocomposite orthopaedic bone cement combining long-acting dual antimicrobial drugs